Evidence map›Paper›PMID 34461452›Full record

ArticlePublic health2021

Is the COVID-19 vaccine effective on the US financial market?

R Khalfaoui, H Nammouri, O Labidi, S Ben Jabeur

Abstract read
In one paragraph

Article in Public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. COVID-19 vaccines and global stock markets.Finance research letters · 2022
    Article
  10. Article
  11. Can Major Public Health Emergencies Affect Changes in International Oil Prices?International journal of environmental research and public health · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

R KhalfaouiLaboratoire de recherche en Économie et Gestion (LR18ES27), Faculté des Sciences Economiques et de Gestion de Sfax, Sfax, Tunisia. Electronic address: rabeh.khalfaoui@gmail.com.
H NammouriInstitute of Sustainable Business and Organizations, Confluence: Sciences et Humanités-UCLy, ESDES, 10 place des archives, 69002 Lyon, France. Electronic address: hnammouri@univ-catholyon.fr.
O LabidiInstitute of Sustainable Business and Organizations, Confluence: Sciences et Humanités-UCLy, ESDES, 10 place des archives, 69002 Lyon, France. Electronic address: olabidi@univ-catholyon.fr.
S Ben JabeurInstitute of Sustainable Business and Organizations, Confluence: Sciences et Humanités-UCLy, ESDES, 10 place des archives, 69002 Lyon, France. Electronic address: sbenjabeur@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCOVID-19 is the most devastating pandemic that affected humanity and the world economy. This paper aimed to study the time-varying connectedness between the COVID-19 vaccination, infection rate (INFR), and the case fatality ratio (CFR) in the United States and the stock market returns. STUDY

designWe used COVID-19 daily confirmed number of infections, deaths, and vaccinations and the daily US stock market index return.

methodsA wavelet coherence approach was used to assess the co-movement of the US stock market with the COVID-19 vaccination, INFR, and the CFR.

resultsThe COVID-19 vaccination, INFR, and CFR have a positive and significant influence on S&P 500 returns at the majority of business cycle frequencies with an in-phase relation.

conclusionsThe wavelet coherence analysis uncovers strong and significant connectedness between COVID-19 vaccination rate and S&P 500 return. From an economic perspective, the US government should continue its intervention with their vaccination strategy, as it is beneficial for fighting the pandemic. This may lead to the recovery of the stock market as well as to the whole economy.

Indexed as

COVID-19COVID-19 VaccinesGovernmentHumansPandemicsSARS-CoV-2United StatesCOVID-19 VaccinesCase fatality ratioCOVID-19Infection rateVaccinationWavelet coherence

Identifiers

PMID34461452
PMCPMC8318694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.